期刊文献+

超声评价前列腺素E_1治疗肺动脉高压疗效 被引量:2

Evaluation of the therapy effects of prostaglandin E_1(PGE_1) on pulmonary hypertension by echocardiography
下载PDF
导出
摘要 目的观察不同剂量前列腺素E1(PGE1)治疗肺动脉高压的效果。方法选择57例不同病种引起的肺动脉高压患者,采用前列腺素E1(PGE1)治疗,分成三组,分别予以20ng/kg/,min,30ng/kg/,min,40ng/kg/minq.d.×7天治疗,观察用药前后肺动脉高压改善情况。结果所有患者治疗后经心超和/或右心导管测定肺动脉压力均有下降。治疗前肺动脉压力愈高改善愈明显,PGE1剂量愈高,改善愈明显。结论心超检查有助于评价PGE,治疗肺动脉高压的疗效。 Objective To evaluate therapy effect on pulmonary hypertension using different dosage of prostaglandin E1(PGE1). Methods 57 selected patients who suffered from pulmonary hypertension for different causes, were divided into three groups. Each group was administrated different dosage of prostaglandin E1 (PGE1),20ng/kg/min,30ng/kg/min, 40ng/kg/min q.d.×7 days respectively, to observe the improvement by monitoring pulmonary artery pressure before and after drug administration. Results The pulmonary artery pressure in all cases decreased significantly measured by echocardiography and/or right heart catherterization. Furthermore ,result shows that the higher pulmonary artery pressure prior to treatment, the more improvement; the higher dosage of PGE1, the more effectiveness. Conclusion Echocardiography examination helps to evaluate the therapy effect of PGE1 on pulmonary hypertension.
出处 《上海医学影像》 2005年第1期71-72,83,共3页 Shanghai Medical Imaging
关键词 治疗后 肺动脉高压 PGE1 前列腺素E1 肺动脉压力 超声评价 患者 疗效 观察 治疗前 Prostaglandin E1 Pulmonary hypertension Dosage
  • 相关文献

参考文献7

  • 1[1]Reynold T: Pulmonary hypertension in The Echocardiographer's Pocket Reference. 2 Edition . Arizona Heart Institute. Phoenix ,Arizona. 2000, 129-134
  • 2[3]毛焕之,杨心.心肌病学.北京:北京人民出版社,1995.706
  • 3[4]Kenneth M: Hemodynamic effect of PGE1 in patients with congential heart disease and pulmonary hypentension. Cath and Cardiovascular Diagnosis, 1991, 24:10-15
  • 4[5]Heart, Weiss CL. Prostaglandin El and intrapulmonary shuntin cardiac surgical patient with pulmonary hyper tension, Ann Thorat Surg, 1990, 49(3):463-465
  • 5高莹,崔大山,周维新,李永顺,柳志红,何建国,张海涛.41例闭塞性肺动脉高压患者应用多普勒超声心动图法与右心导管法测定肺动脉压力的比较[J].中国循环杂志,2004,19(3):216-218. 被引量:13
  • 6[7]Mckenna WJ, Swedberg K, Zannad F, et al. Experiment of chronic intravenous epoprostenal infusion in end stage cardiac failure: Results of first. Eur Heart J, 1994, 15:36-39
  • 7[8]Sueta CA, Gheorghiade M, Aclams KF, et al. Safety and efficaly of epoprostenal in patient with severe congestive heart failure.Am J Cardial, 1995, 75:34-43

二级参考文献4

  • 1Denton CP,Cailes JB,Phillips GD,et al.Comparison of Doppler echocardioraphy and right heart cathetrization to assess pulmonary hypertension in systemic sclerosis.Br Journal of Rheumatology,1997,36:242-243.
  • 2Coats A J,Murphy C,Conway J,et al.Validation of the beat to beat measurement of blood velocity in the human ascending aorta by a new hight temporal resolution Doppler ultrasound spectral analuser.Br Heart J,1992,68:227-228.
  • 3Morgan JM,Criffiths M,Du Bois RM,et al.Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension.Chest,1991,9:551-553.
  • 4高莹,张啸飞,程显声,马秀平,赵彦芬,陈白屏,冯梅.130例闭塞性肺动脉高压患者自然病程的分析[J].中国循环杂志,1999,14(1):28-30. 被引量:2

共引文献12

同被引文献9

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部